Kyung Dong Pharmaceutical Co. Ltd (011040) — Cash Flow Reinvestment Rate
Kyung Dong Pharmaceutical Co. Ltd (011040) has a Cash Flow Reinvestment Rate of 0.31x as of June 2026, reinvesting ₩1.48 Billion (capex ₩842.84 Million plus investments ₩632.23 Million) from operating cash flow of ₩4.75 Billion. See cash generation quality of Kyung Dong Pharmaceutical Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kyung Dong Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for Kyung Dong Pharmaceutical Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see Kyung Dong Pharmaceutical Co. Ltd cash flow conversion.
Annual Cash Flow Reinvestment Rate for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
Year-by-year capital reinvestment analysis for Kyung Dong Pharmaceutical Co. Ltd. See 011040 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.03x | ₩34.36 Billion | ₩16.93 Billion | ₩20.51 Billion | ▲ +56.8% |
| 2021 | 1.29x | ₩16.07 Billion | ₩12.42 Billion | ₩3.93 Billion | ▼ -57.5% |
| 2020 | 3.05x | ₩52.12 Billion | ₩17.12 Billion | ₩28.59 Billion | ▲ +339.0% |
| 2018 | 0.69x | ₩23.07 Billion | ₩33.27 Billion | ₩3.93 Billion | ▲ +15.7% |
| 2017 | 0.60x | ₩8.86 Billion | ₩14.79 Billion | ₩5.74 Billion | ▲ +27.1% |
| 2016 | 0.47x | ₩12.09 Billion | ₩25.63 Billion | ₩7.19 Billion | ▼ -43.6% |
| 2015 | 0.84x | ₩15.27 Billion | ₩18.26 Billion | ₩11.10 Billion | ▼ -11.7% |
| 2014 | 0.95x | ₩21.53 Billion | ₩22.73 Billion | ₩21.17 Billion | ▲ +65.8% |
| 2013 | 0.57x | ₩9.38 Billion | ₩16.42 Billion | ₩9.38 Billion | ▲ +61.4% |
| 2012 | 0.35x | ₩7.06 Billion | ₩19.96 Billion | ₩7.06 Billion | ▲ +277.9% |
| 2011 | 0.09x | ₩2.44 Billion | ₩26.08 Billion | ₩2.44 Billion | — |